Bionano Genomics, Inc. (BNGO)
NASDAQ: BNGO · Real-Time Price · USD
1.140
+0.020 (1.79%)
At close: Jun 26, 2026, 4:00 PM EDT
1.130
-0.010 (-0.88%)
After-hours: Jun 26, 2026, 7:50 PM EDT
Bionano Genomics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Bionano Genomics stock have an average target of 5.00, with a low estimate of 4.00 and a high estimate of 6.00. The average target predicts an increase of 338.60% from the current stock price of 1.14.
Analyst Consensus: Buy
* Price targets were last updated on May 29, 2026.
Analyst Ratings
The average analyst rating for Bionano Genomics stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '25 | Nov '25 | Jan '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 1 | 1 | 1 | 1 | 1 |
| Buy | 2 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Buy Maintains $4 | Buy | Maintains | $4 | +250.88% | May 29, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $7 → $6 | Buy | Reiterates | $7 → $6 | +426.32% | Apr 13, 2026 |
Financial Forecast
Revenue This Year
32.14M
from 28.51M
Increased by 12.73%
Revenue Next Year
43.30M
from 32.14M
Increased by 34.74%
EPS This Year
-2.71
from -4.82
EPS Next Year
-1.11
from -2.71
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 32.5M | 43.3M | |
| Avg | 32.1M | 43.3M | |
| Low | 31.8M | 43.3M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 13.9% | 34.7% | |
| Avg | 12.7% | 34.7% | |
| Low | 11.5% | 34.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | -2.71 | -1.11 | |
| Low | - | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.